EquityZen Growth Technology Fund II LLC - Series 33
Raised
$2M
Investors
31
Min Invest
$5,039
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund II LLC - Series 33 is a Delaware-based pooled investment fund filed by EquityZen Advisors LLC and Philip Haslett. The entity raised $2.3M from 31 investors under Rule 506(b) and 3(c) exemptions, with a $5K minimum investment. This is part of the EquityZen platform, which operates approximately 150 related EDGAR entities focused on private equity investments.
This offering represents a typical small-scale private equity SPV structure with a low $5K minimum investment threshold, targeting accredited investors through the 506(b) exemption. The $74K average check size and 31-investor count are consistent with retail-accessible private equity vehicles, positioned well below institutional minimums but above crowd-accessible thresholds.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
